Mochida Pharmaceutical Co Ltd 2025 Integrated Report
Company: Mochida Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Integrated Report
Pages: 68
The report presents FY2024 consolidated net sales of 105.1 billion yen and identifies five material issues supporting the Group’s business and management foundation. It sets a 46% CO2 emissions reduction target by fiscal 2030 against fiscal 2013 and describes a carbon-neutrality ambition for 2050. The sustainability section also reports 317 terajoules of energy consumption, 347 thousand m3 of water consumption and 511 tons of waste generated.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.